4/A: Medicine Man Technologies Executive Amends SEC Filing to Correctly Report Tax Withholding on Performance Stock Units

Daniel Pabon, Chief Policy and Regulatory Affairs Officer at Medicine Man Technologies, files an amendment to a previous SEC Form 4 to accurately reflect the number of shares withheld for tax obligations related to vested performance stock units.

Summary

• Daniel Pabon, Chief Policy and Regulatory Affairs Officer of Medicine Man Technologies, filed an amended SEC Form 4.
• The amendment corrects an error in the original filing from May 7, 2024, regarding the number of shares issued due to the vesting of performance stock units (PSUs).
• The original filing inadvertently omitted the shares withheld to cover tax obligations.
• The amended form reports that 5,166 shares were withheld on May 3, 2024, at a price of $0.62 per share to cover the tax withholding obligation related to the vesting of PSUs.
• Following the reported transaction, Pabon beneficially owns 10,154 shares of common stock.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a minor error. It doesn't indicate any significant positive or negative developments for the company, but transparency is generally viewed favorably.

Negatives

• The original SEC filing on May 7, 2024, contained an error regarding the number of shares issued due to PSU vesting.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the holdings of company insiders.

Stakeholder Impact

• The correction of the SEC filing ensures accurate information is available to shareholders and potential investors.

Key Dates

Keywords

SEC Form 4, Amendment, Performance Stock Units, Tax Withholding, Beneficial Ownership, Medicine Man Technologies, SHWZ, Daniel Pabon